Randomized clinical trial of post-operative radiotherapy versus concomitant carboplatin and radiotherapy for head and neck cancers with lymph node involvement

Radiotherapy and Oncology

Volumn 87, Issue 2, 2008, Pages 164-172

  Racadot, Séverine ^a   Mercier, Mariette ^b   Dussart, Sophie ^a   Dessard Diana, Bernadette ^c   Bensadoun, René Jean ^d   Martin, Michel ^e   Malaurie, Emmanuelle ^e   Favrel, Véronique ^f   Housset, Martin ^g   Durdux, Catherine ^g   Journel, Catherine ^h   Calais, Gilles ⁱ   Huet, Jocelyne ^j   Pillet, Gérard ^j   Hennequin, Christophe ^k   Haddad, Elias ^l   Diana, Christian ^m   Blaska Jaulerry, Brigitte ⁿ   Henry Amar, Michel ^o   Géhanno, Pierre ^p   Baillet, François ^c   Mazeron, Jean Jacques ^c   more..

^a CENTRE LÉON BÉRARD   (France)

^b HÔPITAL SAINT JACQUES   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d CENTRE ANTOINE LACASSAGNE   (France)

^e Hôpital Intercommunal De Créteil   (France)

^f CENTRE HOSPITALIER LYON SUD   (France)

^g HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^h Department of Radiation Oncology   (France)

ⁱ CHU BRETONNEAU   (France)

^j CENTRE HOSPITALIER SUD FRANCILIEN   (France)

^k SAINT LOUIS HOSPITAL   (France)

^l HENRI MONDOR HOSPITAL   (France)

^m Centre Hospitalier Intercommunal Le Raincy Montfermeil   (France)

ⁿ Centre hospitalier de Lagny Marne la Vallee   (France)

^o CENTRE FRANÇOIS BACLESSE   (France)

^p BICHAT HOSPITAL   (France)

more..

Author keywords

Carboplatin; Chemo radiotherapy; Head and neck cancers; Postoperative

Indexed keywords

CARBOPLATIN; CISPLATIN; FLUOROURACIL;

ADJUVANT THERAPY; ADULT; AGEUSIA; ANEMIA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EDEMA; FEMALE; FOLLOW UP; HEAD AND NECK CANCER; HEARING IMPAIRMENT; HUMAN; INTERMETHOD COMPARISON; LEUKOPENIA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; MUCOSAL NECROSIS; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PHASE 3 CLINICAL TRIAL; POSTOPERATIVE CARE; PRIORITY JOURNAL; RADIATION DOSE; RADIATION INJURY; RANDOMIZED CONTROLLED TRIAL; SKIN FIBROSIS; SKIN TOXICITY; TELANGIECTASIA; THROMBOCYTOPENIA; TRISMUS; XEROSTOMIA;

ANTINEOPLASTIC AGENTS; CARBOPLATIN; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LARYNGEAL NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; OROPHARYNGEAL NEOPLASMS; PROPORTIONAL HAZARDS MODELS; RADIOTHERAPY DOSAGE; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 43049169884     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2007.12.021     Document Type: Article

References (32)

1. Kramer S., Gelber R.D., Snow J.B., et al. Combined radiation therapy and surgery in the management of advanced head and neck cancer: final report of study 73-03 of the Radiation Therapy Oncology Group. Head Neck Surg 10 (1987) 19-30
2. Peters L.J., Goepfert H., Ang K.K., et al. Evaluation of the dose for postoperative radiation therapy of head and neck cancer: first report of a prospective randomized trial. Int J Radiat Oncol Biol Phys 26 (1993) 3-11
3. Snow G.B., Annyas A.A., van Slooten E.A., Bartelink H., and Hart A.A. Prognostic factors of neck node metastasis. Clin Otolaryngol Allied Sci 7 (1982) 185-192
4. Bartelink H., Breur K., and Hart G. Radiotherapy of lymph node metastases in patients with squamous cell carcinoma of the head and neck region. Int J Radiat Oncol Biol Phys 8 (1982) 983-989
5. Byers R.M., Clayman G.L., Guillamondequi O.M., Peters L.J., and Goepfert H. Resection of advanced cervical metastasis prior to definitive radiotherapy for primary squamous carcinomas of the upper aerodigestive tract. Head Neck 14 (1992) 133-138
6. Tupchong L., Scott C.B., Blitzer P.H., et al. Randomized study of preoperative versus postoperative radiation therapy in advanced head and neck carcinoma: long-term follow-up of RTOG study 73-03. Int J Radiat Oncol Biol Phys 20 (1991) 21-28
7. Bachaud J.M., Cohen-Jonathan E., Alzieu C., et al. Combined postoperative radiotherapy and weekly cisplatin infusion for locally advanced head and neck carcinoma: final report of a randomized trial. Int J Radiat Oncol Biol Phys 36 (1996) 999-1004
8. Haffty B.G., Son Y.H., Sasaki C.T., et al. Mitomycin C as an adjunct to postoperative radiation therapy in squamous cell carcinoma of the head and neck: results from two randomized clinical trials. Int J Radiat Oncol Biol Phys 27 (1993) 241-250
9. Weissberg J.B., Son Y.H., Papac R.J., et al. Randomized clinical trial of mitomycin C as an adjunct to radiotherapy in head and neck cancer. Int J Radiat Oncol Biol Phys 17 (1989) 3-9
10. Schwachofer J.H., Crooijmans R.P., Hoogenhout J., Kal H.B., and Theeuwes A.G. Effectiveness of cisplatin and carboplatin in the chemotherapy of squamous cell carcinoma grown as multicellular spheroids. Anticancer Res 10 (1990) 805-811
11. Schwachofer J.H., Crooijmans R.P., Hoogenhout J., Kal H.B., and Theeuwes A.G. Effectiveness in inhibition of recovery of cell survival by cisplatin and carboplatin: influence of treatment sequence. Int J Radiat Oncol Biol Phys 20 (1991) 1235-1241
12. Coughlin C.T., and Richmond R.C. Biologic and clinical developments of cisplatin combined with radiation: concepts, utility, projections for new trials, and the emergence of carboplatin. Semin Oncol 16 (1989) 31-43
13. Ebeling O., Eckel H.E., Volling P., Heitmann K., and Vossing M. Cisplatin/5-FU versus carboplatin/5-FU. 5 year follow-up. HNO 42 (1994) 629-635
14. Douple E.B., Richmond R.C., O'Hara J.A., and Coughlin C.T. Carboplatin as a potentiator of radiation therapy. Cancer Treat Rev 12 (1985) 111-124
15. ICRU. Prescribing, Recording, and Reporting Photon Beam Therapy. Bethesda, MD: International Commission on Radiation Units and Measurements. ICRU Report 50 1993.
16. Freedman L.S. Tables of the number of patients required in clinical trials using the logrank test. Stat Med 1 (1982) 121-129
17. Kaplan E.L., and Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 53 (1958) 457-481
18. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50 (1966) 163-170
19. Cox D.R. Regression models and life-tables. J Roy Stat Soc (B) 34 (1972) 187-220
20. Bernier J., Wibault P., Eschwege F., et al. Interim analysis of EORTC Phase III Trial 22931: after surgery, chemo-radiotherapy (CRT), as compared to radiotherapy alone (RT), significantly increases disease-free survival (DFS), local control (LC) and overall survival (OS) in high-risk head and neck cancer (HNSCC) patients. Ann Oncol 13 (2002) 9 [abstract 29IN]
21. Cox J.D., Stetz J., and Pajak T.F. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 31 (1995) 1341-1346
22. Pignon J.P., and Bourhis J. Meta-analysis of chemotherapy in head and neck cancer: individual patient data vs literature data. Br J Cancer 72 (1995) 1062-1063
23. Pignon J.P., Bourhis J., Domenge C., and Designe L. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer. Lancet 355 (2000) 949-955
24. Weissler M.C., Melin S., Sailer S.L., et al. Simultaneous chemoradiation in the treatment of advanced head and neck cancer. Arch Otolaryngol Head Neck Surg 118 (1992) 806-810
25. Bernier J., Domenge C., Ozsahin M., et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 350 (2004) 1945-1952
26. Cooper J.S., Pajak T.F., Forastiere A.A., et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 350 (2004) 1937-1944
27. Cooper J.S., Pajak T.F., Forastiere A., et al. Precisely defining high-risk operable head and neck tumors based on RTOG #85-03 and #88-24: targets for postoperative radiochemotherapy?. Head Neck 20 (1998) 588-594
28. Rewari A.N., Haffty B.G., Wilson L.D., et al. Postoperative concurrent chemoradiotherapy with mitomycin in advanced squamous cell carcinoma of the head and neck: results from three prospective randomized trials. Cancer J 12 (2006) 123-129
29. Winquist E., Oliver T., and Gilbert R. Postoperative chemoradiotherapy for advanced squamous cell carcinoma of the head and neck: a systematic review with meta-analysis. Head Neck 29 (2007) 38-46
30. Calais G., Alfonsi M., Bardet E., et al. Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. J Natl Cancer Inst 91 (1999) 2081-2086
31. Jeremic B., Shibamoto Y., Stanisavljevic B., et al. Radiation therapy alone or with concurrent low-dose daily either cisplatin or carboplatin in locally advanced unresectable squamous cell carcinoma of the head and neck: a prospective randomized trial. Radiother Oncol 43 (1997) 29-37
32. Bernier J., Cooper J.S., Pajak T.F., et al. Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501). Head Neck 27 (2005) 843-850